Progressive multifocal leukoencephalopathy, natalizumab, and multiple sclerosis - Reply

被引：0
|
作者：
Kleinschmidt-DeMasters, BK [1 ]
Tyler, KL [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1745 / 1745
页数：1
相关论文
共 50 条
  • [21] Multiple sclerosis treatment strategy after natalizumab-associated progressive multifocal leukoencephalopathy
    Waheed, Rasha
    Morales, Fabian Sierra
    Koralnik, Igor
    Stefoski, Dusan
    Ko, Michael
    Bichum, Ouyang
    Warrior, Lakshmi
    NEUROLOGY, 2019, 92 (15)
  • [22] Immune reconstitution inflammatory syndrome occurring in progressive multifocal leukoencephalopathy with natalizumab for multiple sclerosis
    Tan, Ik Lin
    McArthur, Justin C.
    Clifford, David
    Nath, Avindra
    JOURNAL OF NEUROVIROLOGY, 2010, 16 : 86 - 86
  • [23] Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis: A Postmortem Study
    Wuethrich, Christian
    Popescu, Bogdan F. Gh
    Gheuens, Sarah
    Marvi, Michael
    Ziman, Ronald
    Denq, Stephen Pojen
    Tham, Mylyne
    Norton, Elizabeth
    Parisi, Joseph E.
    Dang, Xin
    Lucchinetti, Claudia F.
    Koralnik, Igor J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (11): : 1043 - 1051
  • [24] Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review
    Vivekanandan, Govinathan
    Abubacker, Ansha P.
    Myneni, Revathi
    Chawla, Harsh, V
    Iqbal, Aimen
    Grewal, Amit
    Ndakotsu, Andrew
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [25] Multiple sclerosis treatment strategy after natalizumab-associated progressive multifocal leukoencephalopathy
    Waheed, Rasha
    Warrier, Lakshmi
    Ouyang, Bichun
    Ko, Michael
    Stefoski, Dusan
    Koralnik, Igor
    Morales, Fabian Sierra
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S90 - S90
  • [26] Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    Kraemer, Julia
    Tenberge, Jan-Gerd
    Kleiter, Ingo
    Gaissmaier, Wolfgang
    Ruck, Tobias
    Heesen, Christoph
    Meuth, Sven G.
    PLOS ONE, 2017, 12 (04):
  • [27] Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    Kraemer, J.
    Tenberge, J. -G.
    Kleiter, I.
    Gaissmaier, W.
    Ruck, T.
    Heesen, C.
    Meuth, S. G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 380 - 381
  • [28] Multiple sclerosis treatment strategy after natalizumab-associated progressive multifocal leukoencephalopathy
    Waheed, Rasha
    Warrier, Lakshmi
    Ouyang, Bichun
    Ko, Michael
    Stefoski, Dusan
    Koralnik, Igor
    Morales, Fabian Sierra
    JOURNAL OF NEUROVIROLOGY, 2018, 24 : S90 - S90
  • [29] Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
    Scarpazza, Cristina
    Prosperini, Luca
    Mancinelli, Chiara R.
    De Rossi, Nicola
    Lugaresi, Alessandra
    Capobianco, Marco
    Moiola, Lucia
    Naldi, Paola
    Imberti, Luisa
    Gerevini, Simonetta
    Capra, Ruggero
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 378 : 233 - 237
  • [30] NATALIZUMAB AND THE RISK OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2011, 111 (08) : 23 - 23
12345